Marketing often mars work done in big pharma labs Montreal Gazette And yes, there certainly are skeletons in Big Pharma's closets. Just for a start, there are issues about holding back negative clinical trial data, ...

Jiango Pharma Is in the Bargain Basement Seeking Alpha (blog) By Platinum Tiger Jiangbo Pharmaceuticals (JGBO.OB), a stock I recommended here about two months ago, committed an investor relations gaffe in late February ...

Live-PR.com (press release) Adamis and La Jolla Pharma Kill Merger Deal Xconomy Two San Diego biotechs, Adamis Pharmaceuticals and La Jolla Pharmaceutical , said today they have agreed to terminate their merger agreement, ... La Jolla Pharma to be delisted after merger flop La Jolla says shares will be delisted Thursday

BioSante Pharma to raise $17.5M in stock sale BusinessWeek BioSante Pharmaceuticals Inc. said Thursday it expects to raise $17.5 million by selling stock and options to two institutional investors. ...

Triangle Business Journal Inspire Pharma posts narrower-than-expected Q4 loss Reuters March 4 (Reuters) - Inspire Pharmaceuticals Inc (ISPH.O), which focuses on ophthalmic and pulmonary diseases, reported a narrower-than-expected quarterly ... Inspire Pharma Q4 Loss Narrows Significantly - Update Inspire Posts Smaller Loss as Azasite Sales Rise Inspire Pharma Q4 Loss Narrows - Quick Facts

Jazz Pharma Q4 profit beats Street, raises 2010 view Reuters For 2010, the company expects to earn 27 cents a share to 41 cents, on revenue of $148 million to $158 million. It had earlier forecast earnings of 21 cents ... Jazz Pharmaceuticals , Inc. Announces Fourth Quarter and Full Year 2009 ...

AFP CORRECT: Astellas Begins $3.5B Tender Offer For OSI Pharma Wall Street Journal NEW YORK (Dow Jones)--Astellas Pharma Inc. (ALPMY, 4503.TO) officially launched its cash tender offer Tuesday for all ... OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender ... Astellas sues OSI Pharma to block poison pill plan Deal Profile: Japan's Astellas Pharma Launches Bid for OSI Pharmaceuticals

Archimedes Pharma Raises GBP65 Mln For US Ops, Sales Push Wall Street Journal LONDON (Dow Jones)--Privately-held European pharmaceutical company Archimedes Pharma said Tuesday it raised GBP65 million of new money from investors ... Archimedes Gets $98 Million Injection Archimedes Pharma in largest European funding round of its kind for 15 years Private UK drug firm Archimedes raises 65 mln stg - -

Isis Pharma 4Q Loss Widens; Co Sees 2010 Below Views Wall Street Journal Isis Pharmaceuticals Inc.'s (ISIS) fourth-quarter loss widened amid increased expenses as revenue rose. The pharmaceutical company also said it expects a ... Isis Pharma Q4 Loss Widens - Update Isis Pharma Q4 Loss Widens - Quick Facts

Anthera Pharma Cuts IPO Price In Half After Debut Delay Wall Street Journal Anthera Pharmaceuticals Inc. on Friday cut in half the price of its initial public offering after ... Anthera Pharma again reduces IPO price Anthera Pharma shrinks IPO in weak market Anthera Pharma delays $70M IPO